User profiles for MOHAMMED TANJIMUR RAHMAN

Mohammed Tanjimur Rahman MBBS, PhD

Cleveland Clinic
Verified email at ccf.org
Cited by 1412

[HTML][HTML] Loss of ARID1A expression is related to shorter progression-free survival and chemoresistance in ovarian clear cell carcinoma

A Katagiri, K Nakayama, MT Rahman, M Rahman… - Modern …, 2012 - nature.com
Recently, the ARID1A gene has been identified as a novel tumor suppressor in ovarian clear
cell carcinoma. The prognostic significance of the loss of ARID1A expression is not known. …

[HTML][HTML] CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas

…, MT Rahman, M Rahman… - International …, 2016 - spandidos-publications.com
The clinicopathological significance of amplification was investigated of the gene encoding
cyclin E (CCNE1) and we assessed whether CCNE1 was a potential target in endometrioid …

Clinicopathologic and biological analysis of PIK3CA mutation in ovarian clear cell carcinoma

M Rahman, K Nakayama, MT Rahman, N Nakayama… - Human pathology, 2012 - Elsevier
Somatic mutations of PIK3CA (phosphoinositide-3-kinase) have recently been shown playing
an important role in the pathogenesis of ovarian clear cell carcinoma. In this study, the …

Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma

MT Rahman, K Nakayama, M Rahman, N Nakayama… - Cancer, 2012 - Wiley Online Library
BACKGROUND: The goal of this study was to examine the clinical significance of ZNF217
amplification and assess whether ZNF217 could be a potential therapeutic target in ovarian …

Nanoparticle-mediated synergistic drug combination for treating bone metastasis

MT Rahman, Y Kaung, L Shannon, C Androjna… - Journal of Controlled …, 2023 - Elsevier
Bone metastasis at an advanced disease stage is common in most solid tumors and is
untreatable. Overexpression of receptor activator of nuclear factor κB ligand (RANKL) in tumor-…

Notch3 overexpression as potential therapeutic target in advanced stage chemoresistant ovarian cancer

MT Rahman, K Nakayama, M Rahman… - American journal of …, 2012 - academic.oup.com
This study examined the clinical significance of Notch3 expression and assessed its usefulness
as a potential therapeutic target in chemoresistant ovarian cancer. Notch3 expression …

PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes

M Rahman, K Nakayama, MT Rahman… - Anticancer …, 2013 - ar.iiarjournals.org
Somatic mutations in PPP2R1A, which encodes a scaffolding subunit of serine/threonine
protein phosphatase 2A (PP2A), have recently been described in different types of …

[HTML][HTML] Effects of thrombospondin-4 on pro-inflammatory phenotype differentiation and apoptosis in macrophages

MT Rahman, S Muppala, J Wu, I Krukovets… - Cell Death & …, 2020 - nature.com
Thrombospondin-4 (TSP-4) attracted renewed attention recently as a result of assignment of
new functions to this matricellular protein in cardiovascular, muscular, and nervous systems. …

Expression of nuclear Notch3 in cervical squamous cell carcinomas and its association with adverse clinical outcomes

S Yeasmin, K Nakayama, MT Rahman, M Rahman… - Gynecologic …, 2010 - Elsevier
OBJECTIVE: The aim of this study was to clarify the functional role of Notch3 in human
cervical carcinomas. METHODS: Notch3 expression in cervical cancer was assessed by …

Synergistic combination treatment to break cross talk between cancer cells and bone cells to inhibit progression of bone metastasis

S Vijayaraghavalu, Y Gao, MT Rahman, R Rozic… - Biomaterials, 2020 - Elsevier
Advanced-stage cancers often metastasize to bone, and is the major cause of cancer-related
morbidity and mortality. Due to poor biodistribution of intravenously administered …